“Global demand for Enzymotec Krill oil has dramatically increased during the past year” sources in the company report.
“Enzymotec's goal has always been to ensure its leading position in any business segment it serves, including the krill oil market. As part of our strategy, we have identified several key markets such as the Australian as a keys to our global growth” says Mr. Boaz Noy, head of the BAI division. “I am glad that this strategy pays off. Indeed, we have found that leading producers were able to appreciate Enzymotec exceptional krill oil quality. This quality advantage is based primarily on Enzymotec’s exclusive MSOTM process, developed by its technical team ensuring lasting freshness and potency" concludes Mr. Noy.
“Recently, Aker published a PR regarding a new patent. This patent follows the trend of krill oil-related patents, probably due to its high growth and huge potential. Enzymotec has been involved in the technology of producing krill oil, long before commercialization of krill oil” Says Dr. Sigalit Zchut, Head of R&D. “This patent as well as others does not limit Enzymotec or its customers from selling krill oil in Australia".
Enzymotec, a dynamic biotech company and a leading global developer, is a manufacturer and supplier of lipid-based products and solutions. Enzymotec develops, produces and markets innovative BioActive ingredients and finished products based on sophisticated proprietary technologies. Enzymotec's products support general health, from cardiovascular to cognitive functions.